Relugolix Combination Tablet Franchise in Ahmedabad

Gynaecology Medicine Supplier in Mumbai

Hormonal Therapy Tablet Distributor in Delhi

Women Health Pharma Franchise in Bangalore

Relugolix Combination Tablet Stockist in Hyderabad
Gynaecology Medicine Manufacturer & Exporter in Chandigarh

Home/Products /relugolix-40mg-estradiol-1mg-norethindrone-0-5mg-tablet

About the Product

Description


Ezendiol RN Tablet contains Relugolix 40mg + Estradiol 1mg + Norethindrone 0.5mg, a combination therapy used in the management of hormone-dependent gynaecological conditions, including uterine fibroids and related menstrual disorders.

Relugolix acts as a gonadotropin-releasing hormone (GnRH) antagonist, reducing estrogen production, while Estradiol and Norethindrone provide hormonal balance to minimize estrogen-deficiency symptoms and improve tolerability.

This balanced formulation helps in controlling heavy menstrual bleeding, pelvic discomfort, and hormone-related symptoms, allowing effective long-term management under medical supervision.

Ezendiol RN Tablet is valued for its targeted hormonal control, improved patient comfort, and consistent clinical performance, making it a reliable option in advanced gynaecology and women’s health treatment protocols.

Common side effects may include headache, hot flashes, nausea, fatigue, irregular menstrual bleeding, breast tenderness, and mood changes. Some patients may experience blood pressure changes or mild weight gain. Any unusual bleeding, severe headache, or signs of thromboembolic events should be reported to a doctor immediately.

Ezendiol RN Tablet is indicated for the management of moderate to severe symptoms associated with uterine fibroids and other estrogen-dependent gynecological conditions in adult women. It helps reduce heavy menstrual bleeding and related symptoms while supporting hormonal balance.

Ezendiol RN Tablet should be taken strictly as prescribed by a healthcare professional. It is not recommended during pregnancy or breastfeeding. Regular monitoring may be required for bone mineral density, blood pressure, and lipid profile during long-term use.

Store Ezendiol RN Tablet in a cool, dry place below 25 °C, protected from moisture and direct sunlight. Keep out of reach of children and do not use beyond the expiry date printed on the pack.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Relugolix 40mg + Estradiol 1mg + Norethindrone 0.5mg Tablet in the PCD pharma franchise market?

This combination has strong demand in the gynaecology and hormonal therapy segment, making it a high-value product for medical distributors, wholesalers, and pharma franchise partners focusing on women’s health, hormonal disorders, and specialist gynecology portfolios.

Why should medical distributors include this tablet in their product range?

Medical distributors and agencies can benefit from consistent demand for management of endometriosis, uterine fibroids, heavy menstrual bleeding, pelvic pain, and hormone-related disorders (under specialist supervision). Relugolix 40mg acts as a GnRH receptor antagonist that reduces estrogen production Estradiol 1mg helps maintain hormonal balance and reduce hypoestrogenic symptoms Norethindrone 0.5mg supports endometrial stability and hormonal regulation This combination strengthens a specialized gynecology and hormone-modulation portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for this tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for this advanced gynecology formulation with promotional support, monopoly rights, attractive packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for this product?

Wholesalers and medical agencies benefit from specialist gynecologist prescriptions, hospital and clinic demand, long-term hormonal therapy usage, reliable supply chain support, and strong margins in women’s health medicines.

How can I become a distributor or franchise partner for this tablet?

Interested distributors, stockists, and wholesalers can contact Cafoli LifeCare Pvt Ltd to discuss pricing, monopoly territory rights, and distribution opportunities.